The effect of altered sphingolipid acyl chain length on various disease models

Citations

WEB OF SCIENCE

47
Citations

SCOPUS

53

초록

Sphingolipids have emerged as an important lipid mediator in intracellular signalling and metabolism. Ceramide, which is central to sphingolipid metabolism, is generated either via a de novo pathway, by attaching fatty acyl CoA to a long-chain base, or via a salvage pathway, by degrading pre-existing sphingolipids. As a 'sphingolipid rheostat' has been proposed, the balance between ceramide and sphingosine-1-phosphate has been the object of considerable attention. Ceramide has recently been reported to have a different function depending on its acyl chain length: six ceramide synthases (CerS) determine the specific ceramide acyl chain length in mammals. All CerS-deficient mice generated to date show that sphingolipids with defined acyl chain lengths play distinct pathophysiological roles in disease models. This review describes recent advances in understanding the associations of CerS with various diseases and includes clinical case reports.

키워드

acyl chain length; ceramide synthase; disease; sphingolipid; CERAMIDE SYNTHASE 2; LONGEVITY ASSURANCE GENE-1; FAMILY-MEMBERS; BREAST-CANCER; HUMAN HEAD; (DIHYDRO)CERAMIDE SYNTHASE; INSULIN-RESISTANCE; DOWN-REGULATION; CELL-DEATH; HUMAN CD1D
제목
The effect of altered sphingolipid acyl chain length on various disease models
저자
Park, Woo-Jae; Park, Joo-Won
DOI
10.1515/hsz-2014-0310
발행일
2015-06
유형
Review
저널명
Biological Chemistry
권
396
호
6-7
페이지
693 ~ 705